Vomiting
📧 Sign up to get email alerts when something new happens for Vomiting.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-10-26FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Onesource Specialty Pharma Limited)
FDA approved a supplemental application for ondansetron hydrochloride from Onesource Specialty Pharma Limited. This action updates the regul…
-
CLINICAL_TRIALS trial_result · 2015-10-16Clinical Trial Update: Randomized Trial of the Effectiveness of Topical "ABH Gel" vs. Placebo in Cancer Patients With Nausea [NA]
A randomized trial evaluated the effectiveness of topical ABH Gel versus placebo for nausea in cancer patients; results were posted in 2015.
-
FDA approval · 2015-04-03FDA Approved: ONDANSETRON — Supplemental Application (Qilu Pharmaceutical Co., Ltd.)
FDA approved a supplemental application for ondansetron from Qilu Pharmaceutical Co., Ltd. (ANDA 203711), authorizing a supplemental submiss…
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Ondansetron and the QT Interval In Adult Emergency Department Patients
Completed clinical trial evaluating the effect of ondansetron on the QT interval in adult emergency department patients; results were posted…
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: Aprepitant and Granisetron for the Prophylaxis of Radiation Induced Nausea and Vomiting - A Pilot Study [Phase 2]
A Phase 2 pilot study evaluated aprepitant and granisetron for prophylaxis of radiation-induced nausea and vomiting; the trial has been term…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-10-15FDA Approved: PROCHLORPERAZINE EDISYLATE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved the original application for Prochlorperazine edisylate, a generic product, manufactured by Heritage Pharmaceuticals Inc. (d/b/…
-
FDA approval · 2013-08-30FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Onesource Specialty Pharma Limited)
FDA approved a supplemental application for ondansetron hydrochloride from Onesource Specialty Pharma Limited to permit the marketing of thi…
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Vestibular Dysfunction as a Cause of Chronic Nausea & Vomiting: A Follow up Survey
This clinical trial update reports a terminated, follow-up survey evaluating vestibular dysfunction as a cause of chronic nausea and vomitin…
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: Different Feeding Methods After Pyloromyotomy [NA]
This clinical trial update examines different feeding methods after pyloromyotomy and their effects on vomiting. The study status is complet…
-
CLINICAL_TRIALS withdrawal · 2012-09-13Clinical Trial Update: Domperidone for Relief of Gastrointestinal Disorders [NA]
The clinical trial evaluating domperidone for relief of various gastrointestinal disorders has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: Uncomplicated Nausea and Vomiting in the Emergency Department [Phase 4]
Phase 4 clinical trial evaluating uncomplicated nausea and vomiting in the emergency department has completed.
-
FDA approval · 2012-06-28FDA Approved: PROMETHAZINE HYDROCHLORIDE — Original Application (Cranbury Pharmaceuticals, LLC)
The FDA approved Promethazine hydrochloride as an original generic drug application (ANDA) for Cranbury Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2011-11-24Clinical Trial Update: Intra-abdominal at Cesarean Section: A Randomized Controlled Trial [NA]
A randomized controlled trial sponsored by Virginia Commonwealth University, focusing on nausea and vomiting related to cesarean section, ha…
-
FDA approval · 2011-10-25FDA Approved: COMPRO — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for COMPRO (prochlorperazine) from Padagis US LLC. Prochlorperazine is an antiemetic used to treat n…
-
FDA approval · 2011-10-21FDA Approved: PROCHLORPERAZINE — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for prochlorperazine from Cosette Pharmaceuticals, Inc. for an already approved generic product …
-
FDA approval · 2011-02-28FDA Approved: METOCLOPRAMIDE — Supplemental Application (Genus Lifesciences Inc.)
FDA approved Genus Lifesciences' supplemental application for metoclopramide hydrochloride (metoclopramide), authorizing its generic product…
-
FDA approval · 2011-01-04FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ondansetron hydrochloride from Aurobindo Pharma Limited, adding a new generic product under an A…
-
FDA approval · 2010-12-03FDA Approved: PROCHLORPERAZINE EDISYLATE — Supplemental Application (Civica, Inc.)
FDA approved a supplemental application for Prochlorperazine edisylate from Civica, Inc. to update the labeling per the supplement. The appr…
-
FDA approval · 2010-12-03FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Prochlorperazine maleate submitted by Chartwell RX, LLC under an ANDA.
-
CLINICAL_TRIALS research · 2010-01-29Clinical Trial Update: Placebo in Acupuncture [Phase 2]
Phase 2 clinical trial update examining placebo-controlled acupuncture for nausea and vomiting; status is not specified.
-
EMA withdrawal · 2009-10-13EMA Application withdrawn: Zunrisa (casopitant) — Glaxo Group Ltd
The EMA withdrew the application for Zunrisa (casopitant) from Glaxo Group Ltd for indications in vomiting, postoperative nausea and vomitin…
-
FDA approval · 2009-09-16FDA Approved: METOCLOPRAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for METOCLOPRAMIDE, authorizing the manufacture and marketing of a generic me…
-
FDA approval · 2009-09-11FDA Approved: METOCLOPRAMIDE HYDROCHLORIDE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
FDA approved a supplemental application for METOCLOPRAMIDE HYDROCHLORIDE submitted by Chartwell Governmental & Specialty RX, LLC.
-
CLINICAL_TRIALS trial_result · 2009-08-03Clinical Trial Update: Emend for Multiple-day Emetogenic Chemotherapy [Phase 2]
Phase 2 trial update on Emend for prevention of nausea and vomiting caused by multiple-day emetogenic chemotherapy; study completed with res…
-
FDA approval · 2008-12-18FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved a supplemental application for prochlorperazine maleate from Jubilant Cadista Pharmaceuticals Inc., updating the labeling for t…